Targeting ferroptosis in hepatocellular carcinoma

被引:9
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [31] The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
    Zhao, Siqi
    Zheng, Wubin
    Yu, Chao
    Xu, Gaoxin
    Zhang, Xinyi
    Pan, Chao
    Feng, Yongheng
    Yang, Kunxing
    Zhou, Jin
    Ma, Yong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [32] Ferroptosis in Cancer Immunotherapy-Implications for Hepatocellular Carcinoma
    Kusnick, Johanna
    Bruneau, Alix
    Tacke, Frank
    Hammerich, Linda
    IMMUNO, 2022, 2 (01): : 185 - 217
  • [33] Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
    Piao Luo
    Qian Zhang
    Shuo Shen
    Yehai An
    Lixia Yuan
    Yin-Kwan Wong
    Sizhe Huang
    Shaohui Huang
    Jingnan Huang
    Guangqing Cheng
    Jiahang Tian
    Yu Chen
    Xiaoyong Zhang
    Weiguang Li
    Songqi He
    Jigang Wang
    Qingfeng Du
    Asian Journal of Pharmaceutical Sciences, 2023, 18 (06) : 159 - 176
  • [34] Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
    Luo, Piao
    Zhang, Qian
    Shen, Shuo
    An, Yehai
    Yuan, Lixia
    Wong, Yin-Kwan
    Huang, Sizhe
    Huang, Shaohui
    Huang, Jingnan
    Cheng, Guangqing
    Tian, Jiahang
    Chen, Yu
    Zhang, Xiaoyong
    Li, Weiguang
    He, Songqi
    Wang, Jigang
    Du, Qingfeng
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (06)
  • [35] G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase
    Cao, Fei
    Luo, Anguo
    Yang, Chaowen
    CELLULAR SIGNALLING, 2021, 87
  • [36] Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma
    Liu, Zhiqian
    Ma, Changlin
    Wang, Qi
    Yang, Hao
    Lu, Zhihua
    Bi, Tao
    Xu, Zongzhen
    Li, Tao
    Zhang, Ling
    Zhang, Yajie
    Liu, Jingfang
    Wei, Xiaoqing
    Li, Jie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 589 : 247 - 253
  • [37] Potential biomarkers predicting ferroptosis sensitivity in hepatocellular carcinoma
    Kim, Hyun Young
    Shim, Wan Seob
    Baek, Ga Hee
    Kim, Sang Kyum
    Kang, Keon Wook
    JOURNAL OF HEPATOLOGY, 2023, 78 : S567 - S567
  • [38] New perspectives on ferroptosis and its role in hepatocellular carcinoma
    Cong Tianhao
    Luo Yingen
    Fu Yan
    Liu Yu
    Li Yujie
    Li Xiao
    中华医学杂志(英文版), 2022, 135 (18)
  • [39] Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
    Zuo Fei
    Yin Lijuan
    Zhuang Jing
    Yang Xi
    Pan Yuefen
    Han Shuwen
    Human Cell, 2021, 34 : 177 - 186
  • [40] Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
    Zhong-jie Li
    Hui-qi Dai
    Xiao-wei Huang
    Ji Feng
    Jing-huan Deng
    Zi-xuan Wang
    Xiao-mei Yang
    Yu-jia Liu
    Yong Wu
    Pan-hong Chen
    Huan Shi
    Ji-gang Wang
    Jing Zhou
    Guo-dong Lu
    Acta Pharmacologica Sinica, 2021, 42 : 301 - 310